News Releases

August 16, 2021
DEER PARK, Ill. , Aug. 16, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today reported financial results for the second quarter ended June 30, 2021 .
May 13, 2021
First quarter 2021 revenue of $11.9 million First quarter 2021 operating earnings of $5.4 million ; EPS of $0.19 Eton now has three commercial, revenue-generating products DEER PARK, Ill. , May 13, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical
Displaying 1 - 10 of 13